glucuronic acid has been researched along with Intraocular Pressure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, H; Li, Q; Lin, M; Liu, Y; Ren, J; Zeng, R; Zhao, L; Zuo, C | 1 |
| Haniuda, H; Ito, K; Kashiwagi, K; Ohtsubo, S; Takeoka, S | 1 |
| Shinde, UA; Singh, KH | 1 |
| Aburahma, MH; Mahmoud, AA | 1 |
| Fujisawa, S; Inoue, J; Tokuda, N; Ueno, S; Yamazaki, I | 1 |
| Hassan, MA | 1 |
| Driot, JY; Maurin, F; Sébastian, C; Séchoy, O; Tissié, G; Trinquand, C | 1 |
| Allaire, C; Demailly, P; Trinquand, C | 1 |
1 trial(s) available for glucuronic acid and Intraocular Pressure
| Article | Year |
|---|---|
Ocular hypotensive efficacy and safety of once daily carteolol alginate.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Alginates; Analysis of Variance; Carteolol; Double-Blind Method; Female; Glaucoma, Open-Angle; Glucuronic Acid; Hexuronic Acids; Humans; Instillation, Drug; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Statistics, Nonparametric; Therapeutic Equivalency; Treatment Outcome; Visual Acuity; Visual Fields | 2001 |
7 other study(ies) available for glucuronic acid and Intraocular Pressure
| Article | Year |
|---|---|
The profile of gut microbiota and central carbon-related metabolites in primary angle-closure glaucoma patients.
Topics: Carbon; Citric Acid; Gastrointestinal Microbiome; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Glucuronic Acid; Humans; Intraocular Pressure; RNA, Ribosomal, 16S | 2022 |
Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma.
Topics: Absorbable Implants; Alginates; Animals; Antihypertensive Agents; Aqueous Humor; Behavior, Animal; Chitosan; Cornea; Drug Delivery Systems; Glaucoma; Glucuronic Acid; Hexuronic Acids; Intraocular Pressure; Latanoprost; Nanostructures; Prostaglandins F, Synthetic; Rabbits; Rats; Rats, Sprague-Dawley | 2013 |
Development and Evaluation of Novel Polymeric Nanoparticles of Brimonidine Tartrate.
Topics: Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Alginates; Animals; Brimonidine Tartrate; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Stability; Female; Glucuronic Acid; Hexuronic Acids; Intraocular Pressure; Kinetics; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanotechnology; Particle Size; Rabbits; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2010 |
Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
Topics: Absorbable Implants; Acrylic Resins; Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Alginates; Animals; Brimonidine Tartrate; Calorimetry, Differential Scanning; Cellulose; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Compounding; Glaucoma; Glucuronic Acid; Hexuronic Acids; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Intraocular Pressure; Kinetics; Methylcellulose; Ophthalmic Solutions; Polymers; Polymethacrylic Acids; Polyvinyls; Povidone; Quinoxalines; Rabbits; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; X-Ray Diffraction | 2011 |
Effects of a long-acting ophthalmic formulation of carteolol containing alginic acid on the corneal epithelial barrier function and water retentive effect.
Topics: Adult; Alginates; Antihypertensive Agents; Carteolol; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Epithelium, Corneal; Glucuronic Acid; Hexuronic Acids; Humans; Instillation, Drug; Intraocular Pressure; Ophthalmic Solutions; Water | 2012 |
A long acting ophthalmic gel formulations of atenolol.
Topics: Adrenergic beta-Antagonists; Alginates; Animals; Atenolol; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Delayed-Action Preparations; Gels; Glucuronic Acid; Hexuronic Acids; Intraocular Pressure; Male; Ophthalmic Solutions; Rabbits; Solubility; Time Factors | 2007 |
A new long acting ophthalmic formulation of carteolol containing alginic acid.
Topics: Adhesiveness; Alginates; Animals; Antihypertensive Agents; Biological Availability; Carteolol; Diffusion; Glucuronic Acid; Hexuronic Acids; Intraocular Pressure; Ophthalmic Solutions; Rabbits; Viscosity | 2000 |